Group 1 - The event "Future Industry Special Session of Science Café: Construction and Application of Synthetic Biology Pilot Platforms" was held in Hangzhou, gathering nearly 50 representatives from government, pilot platforms, enterprises, investment institutions, and research institutes to discuss the construction of pilot platforms in synthetic biology manufacturing and industry collaboration development [1][2] - The pilot platform serves as a crucial bridge between laboratory research and large-scale production, providing engineering and product validation to mitigate technology transfer risks and support industrial implementation [1][2] - The Ministry of Industry and Information Technology announced the first batch of 43 selected pilot platforms nationwide, with three units from Zhejiang, including the National Science Wenzhou Research Institute, Zhejiang Marine Development Research Institute, and Hangzhou Chuanhua Technology City Co., Ltd [1][2] Group 2 - Representatives from the three selected units shared their experiences, highlighting the comprehensive innovation service capabilities of the National Science Wenzhou Research Institute's CDMO platform, the marine biological manufacturing pilot platform's capabilities at Zhejiang Marine Development Research Institute, and the integrated "concept verification - pilot - small-scale production" platform at Hangzhou Chuanhua Technology City [2] - The joint notice from the Ministry of Industry and Information Technology and the National Development and Reform Commission aims to cultivate over 20 pilot capacity construction platforms by 2027, serving more than 200 enterprises and incubating over 400 products to support the transition from innovation to industrial application [2] - The demand for specialized pilot platforms is increasingly urgent due to policy incentives and market needs, as evidenced by discussions at the event regarding the challenges and considerations in building these platforms from an industry perspective [3]

Core Insights - The Ministry of Industry and Information Technology (MIIT) of China has released two significant documents regarding the development of biological manufacturing, focusing on high-performance bioreactors and pilot-scale platforms, which aim to advance this emerging productive force in the industry [2][11]. Summary by Sections High-Performance Bioreactors - On November 4, MIIT published a notice listing the selected units for the innovation tasks related to high-performance bioreactors, with 9 key bioreactors and 23 leading universities, research institutes, and enterprises included in the list [2][4]. - Notable participants include companies and institutions such as Womei Biotech, the Chinese Academy of Sciences Tianjin Institute of Industrial Biotechnology, and East China University of Science and Technology [2][5]. Pilot-Scale Platforms - On November 10, MIIT announced the first batch of units selected for the biological manufacturing pilot-scale capability construction platform, comprising 43 units [2][8]. - Among these, 12 units received ratings of four stars or above, including Tianjin University Frontier Research Institute of Synthetic Biology and Beijing University of Chemical Technology Qinhuangdao Bohai Biological Industry Research Institute [3][9]. Key Participants - The list of selected units for high-performance bioreactors includes various leading organizations such as: - Womei Biotech - East China University of Science and Technology - Dibeier Biotechnology - Chutian Technology [5][6]. - The pilot-scale platform includes institutions like: - Beijing Zhaoyan Biotechnology Co., Ltd. - Tianjin University - Chinese Academy of Sciences Tianjin Institute of Industrial Biotechnology [9][10].